Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bio-Path Holdings, Inc. - Common Stock
(NQ:
BPTH
)
0.2100
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bio-Path Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Why Is Bio-Path (BPTH) Stock Up 20% Today?
↗
June 14, 2024
Bio-Path stock is up on Friday with heavy trading of NPTH shares after the company posited positive interim data from a Phase 2 study.
Via
InvestorPlace
Why Bio-Path Stock Is Climbing Today
↗
June 14, 2024
Bio-Path Holdings shares are trading higher Friday after the company announced interim results from its Phase 2 study of prexigebersen in combination with decitabine and venetoclax for the treatment of...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
June 04, 2024
Via
Benzinga
Dow Dips Over 300 Points; GameStop Shares Spike Higher
↗
June 03, 2024
Via
Benzinga
Topics
Stocks
Looking Into Bio-Path Hldgs's Recent Short Interest
↗
May 01, 2024
Via
Benzinga
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
June 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 03, 2024
Via
Benzinga
Crude Oil Down Over 3%; US Construction Spending Falls In May
↗
June 03, 2024
Via
Benzinga
What's Going On With Bio-Path Stock?
↗
June 03, 2024
Bio-Path Holdings shares are trading higher Monday after the company announced the presentation of interim results from its Phase 2 study of prexigebersen (BP1001) in combination with decitabine and...
Via
Benzinga
Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May
↗
June 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 03, 2024
Via
Benzinga
BPTH Stock Earnings: Bio-Path Holdings Misses EPS for Q1 2024
↗
May 15, 2024
BPTH stock results show that Bio-Path Holdings missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
April 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 22, 2024
Via
Benzinga
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
↗
April 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
April 18, 2024
Via
Benzinga
Why Bio-Path Stock Is Soaring
↗
April 18, 2024
Bio-Path Holdings shares are trading higher Thursday after the company announced the completion of its second dose cohort in Phase 1/1b clinical trial of BP1002 evaluating the ability of BP1002 to...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 18, 2024
Via
Benzinga
Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
↗
April 18, 2024
Via
Benzinga
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
April 18, 2024
Via
Benzinga
Walgreens Layoffs 2024: What to Know About the Latest WBA Job Cuts
↗
April 18, 2024
Walgreens layoffs are in the news Thursday after the pharmacy chain announced plans to cut jobs in Chicago while reducing employees' hours.
Via
InvestorPlace
Topics
Workforce
ME Stock Alert: CEO Anne Wojcicki Seeks to Save 23andMe in Take-Private Deal
↗
April 18, 2024
23andMe stock is rallying on Wednesday after the company's CEO announced plans to take ME shares private in a potential deal.
Via
InvestorPlace
Why Is Bio-Path (BPTH) Stock Up 89% Today?
↗
April 18, 2024
Bio-Path stock is up with heavy trading of BPTH shares today alongside positive news from its ongoing clinical trial of BP1002.
Via
InvestorPlace
Dow Surges Over 100 Points; D.R. Horton Posts Upbeat Earnings
↗
April 18, 2024
U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.34% to 37,880.89 while the NASDAQ...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
April 18, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
March 13, 2024
Pre-market stock movers are a great way to start the day with all of the hottest news worth reading about on Wednesday morning!
Via
InvestorPlace
Why Bio-Path Holdings Shares Are Falling Today
↗
March 08, 2024
Bio-Path reported a net loss of $33.63 per share for the year ended Dec. 31, 2023, lower than $38.12 per share in the year-ago period.
Via
Benzinga
Earnings Scheduled For March 8, 2024
↗
March 08, 2024
Companies Reporting Before The Bell • Algonquin Power (NYSE:AQN) is likely to report quarterly earnings at $0.14 per share on revenue of $743.00 million.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
March 07, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today